Trial Profile
The efficacy of DIQUAS ophthalmic solution 3% for dry eye patients before cataract surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2019
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Santen Pharmaceutical
- 26 Mar 2019 Status changed from active, no longer recruiting to completed.
- 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Oct 2017 New trial record